Table 1 Clinical and laboratory parameters of malaria patients and healthy controls
From: Activation of nuclear factor kappa B in peripheral blood mononuclear cells from malaria patients
| Â | P. vivax | Uncomplicated P. falciparum | Complicated P falciparum | Healthy controls | |||
|---|---|---|---|---|---|---|---|
| Â | Day 0 | Day 7 | Day 0 | Day 7 | Day 0 | Day 7 | Â |
Age (years) | 25 (18–36) | 31 (18–55) | 35 (18–57) | 26 (21–33) | |||
Sex (Male/Female) | 11/0 | 10/1 | 10/1 | 7/4 | |||
Duration of fever (days) | 3 (1–5) | 5 (2–9) | 6 (3–9) | None | |||
Parasitaemia (/μl) | 62,916 | 0 | 30,853 | 0 | 825,475# | 0 | None |
WBC (103/μl) | 6.3 | 7.4 | 6.5 | 5.6 | 8.5* | 8.5* | 6.6 |
RBC (106/μl) | 4.9 | 5.0 | 4.1* | 4.1 | 4.2* | 3.6* | 5.1 |
Haematocrit (%) | 39.2* | 39.3* | 32.2* | 32.0 | 34.0* | 28.2* | 44.6 |
Haemoglobin (g/dl) | 13.2* | 13.1 | 10.6* | 10.4 | 11.6* | 9.6* | 14.3 |
Platelet (103/μl) | 97* | 303 | 106* | 353 | 36* | 226* | 245 |